ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/08/2026
Back to search
Official data from USPTO
OPERATING SYSTEM OF LIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OPERATING SYSTEM OF LIFE
ST13
US500000079292986Class
1, 5, 9, 29, 40, 42
Filing
79292986
Registration
6982346
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
01/09/2026
Trademark type
Word
Nice classes
1, 5, 9, 29, 40, 42
Filing date
05/11/2020
Registration date
02/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/21/2023
Last transaction
01/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
GRIFFIN, JAMES
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bit Bio Limited
Representatives
KATRINA G HULL MARKERY LAW LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 29Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnologyother than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology; cell growth mediatissue culture mediacytokinesantibodiesreagents for medical research; all of the foregoing excluding vaccines and RNA-based therapeutics
Class 5
Pharmaceuticals in the nature of cell therapeutics for medicaltherapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagatedcultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medicaltherapeutic or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for medical use in drug screening; Cell preparations for genetic testing and screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cellstissue culture mediacytokinesantibodiesreagents for medical or diagnostic use; Tissue culture mediagrowth factors in the nature of cell growthcell growth medianutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cellsall for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplements
Class 9
Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipmentapparatus for the separation of cell populations for medical or clinical use; all of the foregoing excluding vaccines and RNA-based therapeutics
Class 29
Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fishnot live
Class 40
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposesStem cells for scientific purposesStem cells other than for medical or veterinary purposesSkeletal myocytes for research purposesCortical neurons for research purposesBiological tissue for research and scientific purposesBiological tissue cultures other than for medical or veterinary purposesCultures of cell media other than for medical or veterinary useChemical reagents for use in biotechnologyother than for medical or veterinary useNutritive agents for processing living cells other than for medical useSemi-processed natural proteins for manufacturing foodProteins for use in the manufacture of food productsProteins for use in recombinant DNA technology other than for medical usecell therapeuticsGenetically or otherwise modified cellsCells which are propagatedcultivated and expanded in bioreactorsCells for the purpose of tissue regenerationLiving cells for medical useCells for medical useBiological preparations for medical useDiagnostic preparations for medical and/or veterinary purposesCell preparations for drug screeningCell preparations for genetic testingscreeningStem cells for medical purposesStem cells for veterinary purposesCell growth mediatissue culture mediacytokinesantibodiesreagents for medicalmedical research or diagnostic useTissue culture mediagrowth factorsgrowth mediaserumnutritional supplements for in vitro culturingdevelopmentmaintenanceexpansionassay or manipulation of cellsCell separation reagentsmagnetic cell separation equipmentDietary supplementsProtein supplementsnutrition supplementsMeatMeat substitutesTissue engineered meatSynthetic meatCultured meatLaboratory-grown meat and Fishnot live; all of the foregoing excluding vaccines and RNA-based therapeutics
Class 42
Biotechnology research; Scientific testing for others in the area of biotechnology for researchclinicaltherapeutic and manufacturing purposes; Stem cell research; Synthetic biology servicesbiological research; Stem cell biology servicesbiological research; Scientific services for scientificresearchclinicaltherapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testingscreening; Research and development in relation to drug screening; Cell separation technology services for scientificresearchclinicaltherapeutic and manufacturing purposes; Cell separation research services for scientificresearchclinicaltherapeutic and manufacturing purposes; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discoverycell therapystem cellsmicroorganismshuman tissuessynthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; all of the foregoing excluding vaccines and RNA-based therapeutics
Publications
History of USPTO decisions and trademark events.
52 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/04/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/22/2023
FIMP
FINAL DISPOSITION PROCESSED
05/22/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/21/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/12/2023
OP.T
OPPOSITION TERMINATED NO. 999999
01/12/2023
OP.D
OPPOSITION DISMISSED NO. 999999
01/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/24/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/24/2022
RFNP
REFUSAL PROCESSED BY IB
10/25/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
09/16/2021
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
09/13/2021
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
09/13/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/17/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/28/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
ISMR
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
04/12/2021
ATRV
ATTORNEY REVIEW COMPLETED
04/09/2021
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
04/09/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/22/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/20/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2021
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
01/05/2021
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
12/07/2020
RFNT
REFUSAL PROCESSED BY IB
10/19/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/30/2020
RFRR
REFUSAL PROCESSED BY MPU
09/30/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2020
CNRT
NON-FINAL ACTION WRITTEN
09/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/08/2020
DOCK
ASSIGNED TO EXAMINER
09/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/03/2020
Continuous trademark protection
Get notified about every new filing that threatens OPERATING SYSTEM OF LIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.